All Professionals
Overview
Mengying Li is an associate in the Paul Hastings Hong Kong office. Her practice focuses on capital markets transactions, mergers and acquisitions and listed companies on corporate governance and regulatory matters. She is fluent in English, Mandarin, and Cantonese.
Education
- Harvard University, LLM, 2018
- Tsinghua University, Bachelor of Laws, 2014
Representations
- Represented Morgan Stanley and Huatai Financial Holdings in the listing by way of introduction of Super Hi International Holding Ltd., a spin-off from Haidilao International Holding Ltd., on the Main Board of the Hong Kong Stock Exchange.
- Represented Morgan Stanley, CICC and Futu Securities in the US$394 million global offering and listing of Cheerwin Group, a leading household care and personal care platform in China, on the Main Board of the Hong Kong Stock Exchange.
- Represented CICC, Macquarie Capital, CMBI, BOCI and other underwriters on the US$71 million global offering and listing of TI Cloud Inc., one of the largest providers of customer contact solutions deployed in public clouds in China, on the Main Board of the Hong Kong Stock Exchange.
- Represented Heaven-Sent Gold Group Company Limited, a South African gold mining company, in its proposed initial public offering and proposed listing on the Hong Kong Stock Exchange.
- Represented CITICPE as the controlling shareholder in the HK$507.7 million initial public offering and listing on the Hong Kong Stock Exchange of their portfolio company, ManpowerGroup Greater China Limited, a comprehensive workforce solutions and other HR services provider in Greater China.
- Represented Matrix Partners and LAV as the pre-IPO shareholders in the HK$2.34 billion initial public offering and listing on the Hong Kong Stock Exchange of Peijia Medical Limited, a company engaged in producing replacement heart valve and vascular repair devices, vital for minimally invasive treatment of heart disease, aneurisms and stroke, that have been designed specifically for Chinese patients and healthcare providers.
- Represented China Renaissance, Morgan Stanley, Merrill Lynch, CICC, UBS and other underwriters in the US$250 million initial public offering and listing on the Hong Kong Stock Exchange of Maoyan Entertainment, which is a platform providing innovative Internet-empowered entertainment services in China.
- Represented HSBC, GS, CCBI, CS, ICBCI, CICC, Citi, Merrill Lynch and other underwriters in the US$2.5 billion initial public offering and listing on the Hong Kong Stock Exchange of China Huarong Asset Management Co., Ltd., one of
the largest financial asset management company in China. - Represented China Railway Signal & Communications Corp., one of the world’s biggest providers of train traffic-control systems, in its US$1.42 billion initial public offering on the Hong Kong Stock Exchange.
- Represented Huatai Financial Holdings, JPM, UBS, ICBCI, BNP Paribas, CMS and other underwriters in the US$5 billion initial public offering and listing on the Main Board of the Hong Kong Stock Exchange of HTSC (carrying on business under the Chinese corporate name 华泰证券股份有限公司 in the PRC).
- Represented Linekong Interactive Group Co., Ltd. in its initial public offering and listing on the GEM of the Hong Kong Stock Exchange.
- Represented China Orient Asset Management Co., Ltd. in its introduction of strategic investors.
- Advised listed companies on compliance matters, including JS Global Lifestyle Company Limited, China Huarong Asset Management Co., Ltd. and Hydoo International Holding Limited.